Regeneron Pharmaceuticals, Inc.
MX ˙ BMV ˙ US75886F1075
SecurityMX:REGN / Regeneron Pharmaceuticals, Inc.
InstitutionLPL Financial LLC
Latest Disclosed Ownership63,987 shares
Latest Disclosed Value $ 49,439,153
LPL Financial LLC ownership in REGN / Regeneron Pharmaceuticals, Inc.

On May 6, 2026 - LPL Financial LLC filed a 13F-HR form disclosing ownership of 63,987 shares of Regeneron Pharmaceuticals, Inc. (MX:REGN) valued at $49,439,153 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 11, 2026 disclosing 62,619 shares of Regeneron Pharmaceuticals, Inc.. This represents a change in shares of 2.18% during the quarter.

LPL Financial LLC has a history of taking positions in derivatives of the underlying security (REGN) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD and put options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

MX:REGN / Regeneron Pharmaceuticals, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-06 2026-03-31 13F REGENERON PHARMACEUTICALS COM 75886F107 63,987 1,368 2.18 49,439 2.29 0.0131
2026-02-11 2025-12-31 13F REGENERON PHARMACEUTICALS COM 75886F107 62,619 87 0.14 48,334 37.47 0.0132
2025-11-12 2025-09-30 13F REGENERON PHARMACEUTICALS COM 75886F107 62,532 6,171 10.95 35,160 18.82 0.0102
2025-08-12 2025-06-30 13F REGENERON PHARMACEUTICALS COM 75886F107 56,361 1,116 2.02 29,590 -15.55 0.0099
2025-05-07 2025-03-31 13F REGENERON PHARMACEUTICALS COM 75886F107 55,245 2,455 4.65 35,038 -6.82 0.0136
2025-02-11 2024-12-31 13F REGENERON PHARMACEUTICALS COM 75886F107 52,790 3,171 6.39 37,604 -27.91 0.0153
2024-11-08 2024-09-30 13F REGENERON PHARMACEUTICALS COM 75886F107 49,619 2,377 5.03 52,161 5.05 0.0233
2024-08-07 2024-06-30 13F REGENERON PHARMACEUTICALS COM 75886F107 47,242 6,660 16.41 49,653 27.12 0.0247
2024-05-10 2024-03-31 13F REGENERON PHARMACEUTICALS COM 75886F107 40,582 -1,069 -2.57 39,060 6.77 0.0210
2024-02-14 2023-12-31 13F REGENERON PHARMACEUTICALS COM 75886F107 41,651 918 2.25 36,582 9.13 0.0222
2023-11-13 2023-09-30 13F REGENERON PHARMACEUTICALS COM 75886F107 40,733 3,479 9.34 33,522 25.23 0.0235
2023-07-31 2023-06-30 13F REGENERON PHARMACEUTICALS COM 75886F107 37,254 1,736 4.89 26,769 -8.28 0.0191
2023-05-10 2023-03-31 13F REGENERON PHARMACEUTICALS COM 75886F107 35,518 179 0.51 29,184 14.47 0.0227
2023-02-07 2022-12-31 13F REGENERON PHARMACEUTICALS COM 75886F107 35,339 897 2.60 25,496 7.46 0.0218
2022-11-14 2022-09-30 13F REGENERON PHARMACEUTICALS COM 75886F107 34,442 -662 -1.89 23,726 14.34 0.0229
2022-08-12 2022-06-30 13F REGENERON PHARMACEUTICALS COM 75886F107 35,104 -2,236 -5.99 20,751 -20.43 0.0197
2022-05-16 2022-03-31 13F REGENERON PHARMACEUTICALS COM 75886F107 37,340 -1,569 -4.03 26,079 6.13 0.0224
2022-02-14 2021-12-31 13F REGENERON PHARMACEUTICALS COM 75886F107 38,909 328 0.85 24,572 5.24 0.0206
2021-11-15 2021-09-30 13F REGENERON PHARMACEUTICALS COM 75886F107 38,581 3,746 10.75 23,348 20.00 0.0219
2021-08-13 2021-06-30 13F REGENERON PHARMACEUTICALS COM 75886F107 34,835 -5,222 -13.04 19,457 2.66 0.0197
2021-05-14 2021-03-31 13F REGENERON PHARMACEUTICALS COM 75886F107 40,057 4,849 13.77 18,953 11.43 0.0218
2021-02-12 2020-12-31 13F REGENERON PHARMACEUTICALS COM 75886F107 35,208 4,564 14.89 17,009 -0.85 0.0220
2020-11-09 2020-09-30 13F REGENERON PHARMACEUTICALS COM 75886F107 30,644 -3,173 -9.38 17,154 -18.66 0.0268
2020-08-13 2020-06-30 13F REGENERON PHARMACEUTICALS COM 75886F107 33,817 5,660 20.10 21,090 53.39 0.0367
2020-05-14 2020-03-31 13F REGENERON PHARMACEUTICALS COM 75886F107 28,157 421 1.52 13,749 32.02 0.0296
2020-02-14 2019-12-31 13F REGENERON PHARMACEUTICALS COM 75886F107 27,736 2,054 8.00 10,414 46.18 0.0190
2019-11-13 2019-09-30 13F REGENERON PHARMACEUTICALS COM 75886F107 25,682 -128 -0.50 7,124 -11.82 0.0145
2019-08-09 2019-06-30 13F REGENERON PHARMACEUTICALS COM 75886F107 25,810 -6,356 -19.76 8,079 -38.83 0.0172
2019-05-08 2019-03-31 13F REGENERON PHARMACEUTICALS COM 75886F107 32,166 1,026 3.29 13,208 13.56 0.0300
2019-02-07 2018-12-31 13F REGENERON PHARMACEUTICALS COM 75886F107 31,140 10,012 47.39 11,631 36.24 0.0309
2018-11-14 2018-09-30 13F REGENERON PHARMACEUTICALS COM 75886F107 21,128 329 1.58 8,537 18.98 0.0205
2018-08-14 2018-06-30 13F REGENERON PHARMACEUTICALS COM 75886F107 20,799 5,030 31.90 7,175 32.14 0.0188
2018-05-15 2018-03-31 13F REGENERON PHARMACEUTICALS COM 75886F107 15,769 6,080 62.75 5,430 49.05 0.0149
2018-02-14 2017-12-31 13F REGENERON PHARMACEUTICALS COM 75886F107 9,689 -1,442 -12.95 3,643 -26.80 0.0111
2017-11-14 2017-09-30 13F REGENERON PHARMACEUTICALS COM 75886F107 11,131 2,483 28.71 4,977 17.19 0.0176
2017-08-14 2017-06-30 13F REGENERON PHARMACEUTICALS COM 75886F107 8,648 3,262 60.56 4,247 105.77 0.0161
2017-05-15 2017-03-31 13F REGENERON PHARMACEUTICAL COM 75886F107 5,386 1,899 54.46 2,064 56.01 0.0141
2017-02-13 2016-12-31 13F REGENERON PHARMACEUTICAL COM 75886F107 3,487 383 12.34 1,323 7.30 0.0101
2016-11-16 2016-09-30 13F REGENERON PHARMACEUTICAL COM 75886F107 3,104 3,104 0.00 1,233 0.0117
2016-08-15 2016-06-30 13F REGENERON PHARMACEUTICAL COM 75886F107 0 -27,634 -100.00 0 -100.00
2016-05-16 2016-03-31 13F REGENERON PHARMACEUTICAL COM 75886F107 27,634 -3,336 -10.77 11,154 -29.24 0.0310
2016-02-12 2015-12-31 13F REGENERON PHARMACEUTICAL COM 75886F107 30,970 19,012 158.99 15,763 178.60 0.0437
2015-11-13 2015-09-30 13F REGENERON PHARMACEUTICAL COM 75886F107 11,958 -3,862 -24.41 5,658 -30.18 0.0312
2015-08-14 2015-06-30 13F REGENERON PHARMACEUTICAL COM 75886F107 15,820 973 6.55 8,104 23.73 0.0411
2015-05-14 2015-03-31 13F REGENERON PHARMACEUTICAL COM 75886F107 14,847 1,450 10.82 6,550 19.18 0.0335
2015-02-13 2014-12-31 13F REGENERON PHARMACEUTICAL COM 75886F107 13,397 591 4.62 5,496 20.69 0.0301
2014-11-10 2014-09-30 13F REGENERON PHARMACEUTICAL COM 75886F107 12,806 602 4.93 4,554 32.11 0.0272
2014-08-05 2014-06-30 13F/A-1 REGENERON PHARMACEUTICAL COM 75886F107 12,204 343 2.89 3,447 -3.23 0.0201
2014-08-05 2014-06-30 13F REGENERON PHARMACEUTICAL COM 75886F107 12,204 1,693
2014-05-12 2014-03-31 13F REGENERON PHARMACEUTICAL COM 75886F107 11,861 455 3.99 3,562 13.48 0.0219
2014-02-13 2013-12-31 13F REGENERON PHARMACEUTICAL COM 75886F107 11,406 8,951 364.60 3,139 332.37 0.0196
2013-11-04 2013-09-30 13F REGENERON PHARMACEUTICAL COM 75886F107 2,455 -1,407 -36.43 726 -16.36 0.0048
2013-08-15 2013-06-30 13F REGENERON PHARMACEUTICAL COM 75886F107 3,862 3,862 868 0.0062
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2025-05-07 2025-03-31 13F REGENERON PHARMACEUTICALS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2025-02-11 2024-12-31 13F REGENERON PHARMACEUTICALS COM Call 1,700 1,211 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2025-02-11 2024-12-31 13F REGENERON PHARMACEUTICALS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2024-11-08 2024-09-30 13F REGENERON PHARMACEUTICALS COM Put 200 210 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.